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Abstract 
Human Papillomavirus (HPV) is the most common sexually transmitted infection in 
the U.S and can lead to several types of cancers. A better understanding of the 
variables impacting HPV vaccination will help inform the development of effective 
disease prevention interventions. This study aims to describe factors that impact 
parents’ and caregivers’ decisions to vaccinate their children against HPV by 
examining sociocultural factors and behavioral change theory among parents or 
caretakers of sons and daughters (ages 9-18) from diverse socioeconomic, racial, and 
ethnic backgrounds. A national sample was recruited and participants completed 
demographic questions and measures related to their attitudes and beliefs about the 
vaccine and measures based on the transtheoretical model. These variables were used 
to predict child vaccine initiation and to validate existing measures using a novel 
sample. Health care provider recommendation, perceived vaccine effectiveness, pros 
for vaccination, and self-efficacy increased the likelihood that children had initiated 
the HPV vaccine. While no significant differences were found for race/ethnicity and 
gender on vaccine initiation, some disparities were noted. There were regional 
differences in perceived cons for vaccination, socioeconomic differences in self-
efficacy and perceived effectiveness, and gender differences in health care provider 
recommendation and parent perception of cons, vaccine harm, and barriers. These 
findings may inform future, tailored interventions aimed at increasing HPV vaccine 
initiation among children and adolescents.
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Introduction 
Human papillomavirus (HPV) is the most common sexually transmitted 
infection (STI) and high-risk types can cause cancer (Baseman & Koutsky, 2005). 
Cervical cancer rates are higher in Black and Latina communities (National Cancer 
Institute, 2011; Ward et al., 2004). Disparities in uptake of the HPV vaccine will 
further perpetuate disparities in cancer rates. Health related behaviors are often 
influenced by sociocultural factors. A better understanding of the variables impacting 
HPV vaccination will help inform the development of effective disease prevention 
interventions. This study aims to describe differences in HPV vaccine uptake among 
parents or caretakers of sons and daughters (ages 9-18) from diverse socioeconomic, 
racial, and ethnic backgrounds. Racial/ethnic disparities, beliefs and perceptions about 
the vaccine, barriers to obtaining the vaccine, gender differences, health behavior 
change variables, and parent-child communication about vaccination and sexual health 
will be examined.  
Human Papillomavirus and Vaccination 
HPVs are a group of viruses that infect the skin and mucous membranes. There 
are over 100 different types of HPV and more than 40 of these types are transmitted 
sexually. HPV is the most common STI in the U.S. (National Cancer Institute, 2013). 
The highest rates of HPV infection are found among sexually active individuals 
between the ages of 15-24 and in the U.S., over 14 million people contract a new HPV 
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infection every year (American Cancer Society, 2013). High-risk HPV types can cause 
cervical, vaginal, vulvar, anal, penile, and head/neck cancers. High-risk types are 
responsible for about 70% of cervical cancers (de Sanjose et al., 2010), almost all anal 
cancers, 40% of penile cancers, and 25-35% of oral cancers (Parkin & Bray, 2006; 
Watson et al., 2008). Low-risk HPV types cause cervical cell changes and cause 90% 
of genital warts (Gerend & Barley, 2009). The majority of HPV infections are 
asymptomatic and clear without medical intervention. However, around 10% of 
women who contract “high risk” HPV will develop persistent infections that can cause 
cervical cancer (Ault, 2006).  
In 2006, the Food and Drug Administration approved Gardasil®, a vaccine that 
helps protect against the HPV types that are responsible for 70% of cervical cancer. It 
is recommended for males and females aged 9-26 years old (Centers for Disease 
Control and Prevention, 2006; Center for Disease Control and Prevention, 2011). 
Gardasil is a three dose vaccine series administered over six months. The Advisory 
Committee on Immunization Practices recommends universal vaccination of all 11-12 
year old children as vaccination is preferable before sexual debut to optimize the 
protective benefits. However, “catch-up” vaccination of individuals aged 13-26 is also 
recommended (Dempsey, Gebremariam, Koutsky & Manhart, 2008).  
A national survey found that only 28.9% of girls aged 11-17 years had 
received at least 1 dose of the vaccine and that only 14.2% had received all 3 doses 
(Laz, Rahman, & Berenson, 2012). Currently, less is known about vaccine uptake 
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among males. Using national samples, two studies found that in the first year after 
licensure, only 1-2% of adolescent boys had received at least 1 dose of the vaccine 
(Reiter, McRee, Kadis, & Brewer, 2011; Center for Disease Control and Prevention, 
2011). Finding ways to increase vaccine uptake are very important. A recent study 
found a 56% decrease in vaccine type HPV prevalence among a nationally 
representative sample of females 14-19 years old in the vaccine era (2007-2010) when 
compared with the prevaccine era (2003-2006) (Markowitz et al., 2013). 
Racial/Ethnic disparities  
In the U.S., cervical cancer incidence and mortality rates are higher in Black 
women than White women (National Cancer Institute, 2011). Rates of cervical cancer 
among African-American women remain 39% higher than among White women 
(American Cancer Society, 2011). In addition, cervical cancer mortality rates are more 
than twice as high among African-American women as among White women. 
Similarly, when compared with White women, age-adjusted cervical cancer incidence 
rates are 80% higher among Latinas (Ward et al., 2004). Universal HPV vaccination 
could potentially reduce racial and ethnic disparities in cancer prevalence and 
mortality. Unfortunately, those most at risk for vaccine-preventable disease are 
generally the least likely to obtain them, such as Latinos (Mays, Stru, & Zimet, 2004).  
Awareness of HPV and HPV vaccination appear to be quite high. Jain and 
colleagues (2009) found that 84.3% of the women they surveyed (aged 18-49) had 
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heard of HPV and 78% of the women had heard of the HPV vaccine. However, 
awareness varied by racial/ethnic group, education level and insurance coverage. 
Black women and Hispanic women were less likely to be aware of the vaccine 
compared to non-Hispanic white women. Many disparities remain largely 
unexplained. Due to the age recommendation for vaccination, psychosocial variables 
among parents and care givers should be further examined. 
Predictors of parents’ acceptance and intention to vaccinate  
Several studies have examined predictors of HPV vaccine adoption. Wong and 
colleagues (2011) found that parental education of less than high school level, well-
child check and influenza shot in the past year, and parental familiarity with the HPV 
vaccine were associated with higher vaccine uptake among girls ages 9-17 years. 
Another study describing HPV vaccination among adolescent girls in high-risk 
communities found that parent awareness of the vaccine, belief in vaccine 
effectiveness, and doctor recommendation were positively associated with vaccine 
initiation. They also found that negative attitudes toward the vaccine and needing 
more information about the vaccine were negatively associated with vaccine initiation 
(Guerry et al., 2011). Brewer and colleagues (2011) found that rates of vaccine 
initiation were higher among parents who perceived lower barriers to getting the 
vaccine, anticipated greater regret if their daughters got HPV and were not vaccinated, 
or were not born-again Christians.  
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Acceptance of the vaccine appears to be high in many communities. Bair, 
Mays, Sturm, and Zimet (2008) found that acceptance of the HPV was high in a 
sample of Latina mothers. They found that the reasons for not accepting the vaccine 
included a lack of information and feeling that their daughters were too young. Pierre 
Joseph and colleagues (2012) found that African-American mothers were more 
knowledgeable and accepting of the HPV vaccine than Haitian Immigrant mothers. 
Most African-American mothers felt that vaccination fell within the parental role, 
whereas most Haitian mothers felt uncomfortable vaccinating against STIs as they felt 
children should not be sexually active and reported discomfort discussing sex. 
Providers should focus on providing information about the rationale for vaccination in 
early adolescence and vaccine safety as they could potentially play a role in opening 
discussions about the protection that vaccination would provide, while remaining 
culturally sensitive.  
Physician recommendation appears to be an extremely important predictor of 
vaccine uptake and may also play a role in vaccine disparity. Litton and colleagues 
(2011) did not find race, education, religion, knowledge, or perceived susceptibility to 
be significantly associated with intention to vaccinate their daughter in a sample of 
racially diverse caregivers from Alabama. However, they did find that the caregivers 
who were informed by their health care providers about the vaccine were more likely 
to vaccinate their adolescent daughters. Hamlish, Clarke, and Alexander (2012) 
examined motivators and barriers to HPV vaccination among African-American 
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mothers. They found that the mothers trusted physicians to initiate discussion of HPV 
vaccination and those physicians who failed to initiate the discussion generated doubt 
about the vaccine among the mothers.  Ylitalo, Lee, and Mehta (2013) examined 
national data and found that when adolescents were provided with a health care 
provider recommendation for vaccination they were almost 5 times as more likely to 
receive the vaccine than those without a recommendation. This association between 
recommendation and vaccination appeared strong across all racial/ethnic groups; 
however, they found that racial/ethnic minorities were less likely to receive a 
recommendation. Further, Polonij and Carpiano (2013) found that the odds of 
receiving a recommendation were negatively associated with SES and black racial 
status.  
Gender differences 
Mothers appear to show more willingness to vaccinate daughters. Linddon, 
Hood, Wynn, and Markowitz (2010) conducted a literature review and found that 
among mothers of sons, support of HPV vaccination varied widely from 12% to 
100%. They also found that a preference to vaccinate females over males was reported 
in a majority of studies. This appeared to be due to the belief that the vaccine would 
not directly benefit males. A recent study found similar results, women with only a 
daughter were more willing than those with a son to vaccinate their child (71% vs 
44%), mothers of both daughters and sons were more willing to vaccinate their 
daughters (67% vs 39%), and mothers of sons as compared to daughters were less 
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likely to consider their child at risk of HPV (27% vs 12%) (Berenson & Rahman, 
2012).  
Gilkey, Moss, McRee, and Brewer (2012) found that among sons, initiation of 
HPV vaccine was lower for those living in high income households and higher for 
those whose race was neither white nor black. Parents of unvaccinated sons were more 
likely than those of daughters to report not getting a physician’s recommendation or 
not being aware that the vaccine was available for their son. Factors such as perceived 
benefit of HPV vaccine appear to differ by child’s gender, it is important to continue 
filling in gaps in the literature by examining gender differences among parents in their 
intention to vaccinate their children against HPV.  
Most studies examining adolescent HPV vaccine uptake surveyed mothers or 
female caregivers only. However, some studies surveyed male and female caregivers 
(Brewer, et al, 2011; Guerry et al., 2011; Gilkey et al., 2012). Among these studies, 
most respondents were female (between 88-91%). Attitudes and beliefs about HPV 
vaccination among both male and female caregivers should be further explored to 
identify potential differences across gender.  
Parent Communication about sex and vaccination  
 Parent-child communication about sex is associated with decreased sexual risk 
taking during adolescence and an older age at sexual debut (DeClemente et al., 2001; 
Miller et al., 1998). Parents should have conversations about sex early for them to be 
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most effective. Communication about sex should ideally begin before children begin 
having sex (Miller et al., 1998). However, parents often underestimate their child’s 
level of sexual activity. Beckett and colleagues (2010) found that 40% of youth had 
intercourse before their parents talked with them about safe sex. Additionally, Latina 
and Asian mothers have been found to be less likely to discuss sex with their 
daughters when compared to Black and White mothers (Meneses, Orrell-Valente, 
Guendelman, Oman, & Irwin, 2006). Many parents rely on situations that arise 
spontaneously to prompt conversations with their children about safe sex. External 
cues, such as a child’s sex education class can prompt parents to initiate conversations 
about sex (Rosenthal, Feldman, & Edwards, 1998; O’Sullivan, Meyer-Bahlburg, & 
Watkins, 2001).  
 Discussions about the vaccine may provide parents with an opportunity to talk 
with their children about STIs and safe sex. Communication about the HPV vaccine 
has been examined as a potential cue for mother-daughter communication about sex. 
McRee and colleagues (2012) found that 65% of mothers reported talking with their 
daughters about the HPV vaccine, of whom 41% reported that led to a conversation 
about sex. Mothers who talked with their daughters about HPV vaccination were more 
likely than those who had not to have also talked with them about sex (92% vs. 74%). 
Among the mothers who talked about sex when they talked about HPV vaccination, 
many felt that the vaccine provided a good reason to talk about sex (64%) or that it 
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made it easier to start the conversation (33%). To date, no study has examined the 
relationship between parent-son communication about sex and the HPV vaccine.  
Transtheoretical Model 
 The Transtheoretical Model (TTM) is an integrated and comprehensive model 
of behavioral change (Prochaska & Velicer, 1997). The TTM describes intentional 
behavior change through a series of five stages that result in long-term maintenance of 
the behavior: Precontemplation, Contemplation, Preparation, Action and Maintenance 
(Naar-King et al., 2006). These stages have been used to look at readiness to obtain 
the vaccine among college women. The TTM provides an integration of processes and 
principles of change from different theories, including Janis and Mann’s (1977) model 
of decision making and Bandura’s (1977) construct of self-efficacy (Schumann et al., 
2005).  
The TTM has been validated for many health-related behaviors including 
smoking, mammography screening and increasing condom use (Levy, 1997). When 
TTM constructs mentioned above are combined using validated measures, tailored 
interventions can be developed to target behavioral change. TTM measures of self-
efficacy and decisional balance for HPV vaccination were validated among college 
women (Lipschitz et al., 2013). These measures were developed to examine a 
participants’ confidence in their ability to complete the vaccine series and to measure a 
participants’ pros and cons for receiving the vaccine. TTM-tailored interventions are a 
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promising option to increase vaccination. Before developing an intervention for 
caregivers, TTM measures should be validated within this unique population.  
Brief interventions have been shown to be effective in increasing 
understanding of HPV and increasing positive attitudes towards vaccination in adult 
women (Doherty & Low, 2008). By gaining a better understanding of the variables 
that predict vaccine adoption among children and adolescents, interventions can be 
created and aimed at increasing vaccination at earlier ages. Interventions should be 
based on health behavior change theory in order to reach parents at different stages of 
change. Demographic variables should be considered to develop culturally competent 
interventions. Parent-child communication about sex and vaccination should be 
examined to develop better ways to promote safer sex. 
The purpose of the current study is to examine differences in HPV vaccine 
uptake and parent-child communication about sex among parents/caregivers and their 
children. Predictors of HPV vaccination in a sample of diverse parents/caregivers will 
also be examined. The study extends previous research in several ways. Both parent 
and child demographics, parent attitudes and beliefs about the HPV vaccine, TTM 
variables, and parent-child communication about sex will be examined to determine 
whether they add unique variance in the prediction of vaccination. These variables will 
be used to predict the likelihood of falling into one of the two categories (vaccine 
initiated vs. vaccine uninitiated). The initiated group will be defined as having begun 
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the vaccine series (the series is contained within three shots: baseline, 2 months and 6 
months). Specifically it is expected that: 
Hypothesis 1: When parents/caregivers have received a health care provider’s 
recommendation, their child will be more likely to have initiated the vaccine 
series. 
Hypothesis 2: When parents perceive the vaccine as effective, their child will 
be more likely to have initiated the vaccine series, as measured by the CHIAS 
effectiveness subscale. 
 Hypothesis 3: When parents perceive the vaccine to be potentially harmful, 
 their child will be less likely to have completed the vaccine series, as measured 
 by the CHIAS harms subscale.  
 Hypothesis 4: When parents perceive barriers to vaccination, their child will 
 be less  likely to have initiated the vaccine series, as measured by the CHIAS 
 barriers subscale.  
Hypothesis 5: When parents feel uncertain about the vaccine, their child will 
be less likely to have initiated the vaccine, as measured by the CHIAS 
uncertainty subscale.  
 Hypothesis 6: Given the findings related to racial/ethnic differences in vaccine 
 adoption rates, the percent initiating the vaccine series will differ by 
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 racial/ethnic group. Racial and ethnic minorities will be less likely to have 
 initiated the vaccine series.  
 Hypothesis 7: Given the findings related to gender differences in vaccine 
 adoption rates, female children will be more likely to have initiated the vaccine 
 series.  
 Hypothesis 8: Given the findings related to gender differences in vaccine  
 uptake rates, among parents who haven’t initiated the vaccine, those with sons 
 will be less willing to initiate vaccination as they may perceive that 
 their sons are less likely to benefit from the vaccine when compared to 
 parents of daughters.  
Hypothesis 9: Parents who talked to their child about HPV vaccination will be 
more likely than those who had not to have also talked with them about safe 
sex, as measured by the UNC Mother-Daughter Survey.  
Hypothesis 10: In accordance with the TTM’s decisional balance construct, the 
children of parents who have more pros and fewer cons for receiving the HPV 
vaccination will be more likely to have initiated the vaccine series, as 
measured by the Decision Balance for HPV scale.  
Hypothesis 11: The children of those parents who have more vaccine self-
efficacy (i.e., higher confidence) will be more likely to have initiated the 
vaccine series, as measured by the Self-efficacy for HPV scale.  
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Hypothesis 12: When all significant variables are looked at together, TTM 
variables (decisional balance, self-efficacy) will be the strongest predictors of 
HPV vaccine initiation.  
Hypothesis 13: TTM measures of decisional balance and self-efficacy will be 
validated in a population of male and female parents/caregivers.  
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Method 
Participants  
 Parents and caregivers were recruited using Survey Sampling International 
(SSI) and informal recruitment (i.e., emailing colleagues) using an online survey. A 
total of 335 participants began the online survey. However, 26 were removed from the 
data set because they indicated that they were not a parent or caregiver of a child 
between the ages of 9-18 during the initial screening question. Another 16 participants 
were removed from the data set as they quit before they completed the demographic 
questions. A total of 292 participants were included in the final data set.  
Measures  
 Demographic questions. The online questionnaire presented to participants 
included a series of demographic questions about the participants and their children 
including: gender, race/ethnicity (white, non-white), age, sexual orientation, country 
of origin, current state and region in which they reside (South, Northeast, Midwest, 
West), highest level of education (four years of college or more, some college, high 
school diploma/GED or less), household income (under $25,000, $25,000-$50,000, 
$50,000-$75,000, $75,000 or more, choose not to answer), and various questions 
about their child’s vaccination status. Participants with more than one child between 
the ages of 9-18 were asked to think about their child that had the most recent birthday 
when answering the questions.  
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Decisional Balance for HPV vaccination. Developed by Lipschitz and 
colleagues (2011), the Decisional Balance scale is an 8-item questionnaire measuring 
the Pros and Cons of completing the vaccine series. Four items represent the Pros of 
receiving the vaccine series and four items represent the Cons of receiving the vaccine 
series. An example of a Pros item is “Protecting my child from HPV would make me 
feel good”. An example of a Cons item is “Receiving the series of three shots would 
take too much time”. The items are measured using a 5-point Likert scale ranging 
from 1 = ‘Not Important’ to 5 = ‘Extremely Important’. Responses are summed for the 
Pros items and the Cons items separately, producing two continuous predictor 
variables. Higher scores represent higher perceptions for the pros and cons variables. 
According to the authors, internal consistency is good for the Pros scale (α=0.90) and 
adequate for the Cons scale (α=0.66). In the current study, the Cronbach alpha 
coefficient was good for the Pros scale (α=0.86) and the Cons scale (α=.88).  
Self-Efficacy for HPV vaccination. Developed by Lipschitz and colleagues 
(2011), the Self-Efficacy scale is a 6-item questionnaire aimed at measuring 
participants’ confidence in their ability to complete the vaccine series in situations that 
may prove challenging. An example of an item is “When I think about the possible 
side effects of the vaccine”. Items are measured on a 5-point Likert scale, ranging 
from 1=”Not at All Confident” to 5=”Extremely Confident.” All items are summed 
producing a continuous predictor variable. Higher scores represent higher perceptions 
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for self-efficacy. According to the authors, internal consistency is good (α=0.84). In 
the current study, the Cronbach alpha coefficient was good (α=.89).  
 The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS). 
Developed by McRee and colleagues (2010), the CHIAS is a 16-item questionnaire 
aimed at measuring a range of parent attitudes and beliefs about HPV vaccine. The 
authors identified four CHIAS subscales, all of which had acceptable scale alphas and 
one-year test-retest reliability. An example of an item from the Perceived Harms 
subscale is “The HPV vaccine might cause short term problems, like fever or 
discomfort”. The items are measured using a 4-point Likert scale ranging from 1= 
‘Strongly Disagree’ to 4= ‘Strongly Agree’. Responses are reverse scored and 
summed for each subscale, producing four continuous predictor variables. Higher 
scores represent higher perceptions of Perceived Harm, Barriers, Effectiveness, and 
Uncertainty. According to the authors, the subscales include Perceived Potential 
Harms of HPV vaccination (α=.69), Perceived Barriers to vaccination (α=.69), 
Perceived Effectiveness of HPV vaccination (α=.61), and Uncertainty about HPV 
vaccination (α=.66). In the current study, the Cronbach alpha coefficient was good for 
Perceived Potential Harms (α=.84), Perceived Barriers (α=.92), Perceived 
Effectiveness (α=.83), and adequate for Uncertainty (α=.45).  
 UNC Mother-Daughter Communication Survey. Developed by McRee and 
colleagues (2009), the mother-daughter communication survey is based on established 
measures in the literature (Miller et al., 2009) as well as HPV vaccine research 
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involving parents of adolescent girls (Reiter, et al., 2009; McRee et al., 2011). The 
survey assesses mother-daughter communication about sex, mother-daughter 
communication about HPV vaccination, and other potential cues to talking about sex. 
Questions were reworded to include sons and fathers. An example of an item is “I 
think that my child should wait until he/she is married to have sex”. Some items are 
measured using a 5-point Likert scale, ranging from 1=’Strongly Disagree’ to 
5=’Strongly Agree’. Other items are measured with a ‘Yes’ or ‘No’. Individual items 
were used to examine parent-child communication about HPV vaccination and safe 
sex. 
Procedure  
 Parents and caregivers were recruited using SSI and informal recruitment  
using an online survey. SSI is a global provider of sampling solutions for survey 
research and data collection and provided recruitment of national data. National data 
was census balanced for race/ethnicity and geographical region. Only parents and 
caregivers of children or adolescents between the ages of 9-18 were eligible for this 
study as Gardasil® is only recommended for children starting at age 9. Participants 
recruited through SSI earned points for completing the survey which could be 
exchanged for small prizes. Informally recruited participants were not offered any 
incentive for completing the survey. Following Institutional Review Board approval, 
participants completed the survey via SurveyMonkey.com. The participants were first 
given Informed Consent to Participate in Research and brief instructions. All 
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responses were kept anonymous to protect participant’s privacy. Following that, the 
survey began and participants were asked to try to complete all of the included 
questions. 
Data Analysis  
 Descriptive statistics were run to examine outliers, means, standard deviations, 
skewness, kurtosis, frequencies, and correlations among variables. A series of 
independent-samples t-tests, one-way ANOVAs, and chi-squares were run to explore 
demographic group differences across TTM and CHIAS variables. Logistic regression 
analysis was conducted to examine the likelihood of falling into one of the two 
outcome categories (initiated vaccine vs. did not initiate vaccine) given the categorical 
and continuous predictor variables described in hypotheses 1-12. A confirmatory 
factor analysis (CFA) was used to validate the use of the TTM measures within this 
sample of parents and caregivers. Missing data as well as preliminary assumption 
testing were assessed. All analyses were performed using IBM SPSS v. 22 and EQS. 
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Results 
Description of the Sample 
 The final sample was composed of 292 parents and caregivers between the 
ages of 27 and 64 (M=40.67, SD=7.94). The participants identified as White (69.9%), 
Latino/Latina (11.6%), Black/African American (11%), Asian (4.8%), American 
Indian (1.4%), Native Hawaiian or Pacific Islander (.3%), and Other (1%). The modal 
participant identified as a mother (63%), heterosexual (93.5%), married (77.4%), had a 
4-year degree or higher (52%), had an estimated household income of 75,000 or 
higher (45.9%), were born in the United States (89.7%), were currently living in the 
northeast (35.3%), and had two children (38%). The children were between nine and 
18 years old (M =12.38, SD =3.08). The modal child described by participants was 
female (54.1%), White (66.4%), had not completed the HPV vaccine series (64.7%), 
and had not started the vaccine series (50.3%). Complete demographic information for 
the sample are presented in Table 1. 
Exploratory Analyses  
 Descriptive statistics for the TTM and CHIAS measures are shown in Table 2. 
Exploratory analyses were run to examine demographic group differences in 
vaccination, TTM variables, and attitudes and beliefs about HPV vaccination (see 
Tables 3 and 4).  
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Demographics differences on TTM, CHIAS, vaccine completion, vaccine 
initiation, and health care provider recommendation.    
Parent Race. There were no significant differences in scores for race/ethnicity 
on the TTM variable scores (pros, cons, self-efficacy) or CHIAS (perceived harm, 
barriers, effectiveness, uncertainty) scores. Additionally, there was no significant 
association between race/ethnicity and vaccine completion, initiation, or health care 
provider recommendation.  
Child Gender. There was a significant difference in cons for vaccination 
series between male children (M=52.47, SD=10.73) and female children (M=47.85, 
SD=8.83); t (289) = -4.039, p= .000, two-tailed. There was a significant difference in 
CHIAS perceived harm for vaccination scores between male children (M=51.24, 
SD=10.31) and female children (M=48.85, SD=9.58); t (288) = -2.044, p= .042, two-
tailed. There was a significant difference on CHIAS barriers for vaccination scores 
between male children (M=52.50, SD=10.89) and female children (M=47.89, 
SD=8.69); t (288) = -3.94, p= .000, two-tailed. There were no significant differences 
in scores for child gender on the pros, self-efficacy, effectiveness, or uncertainty 
scores. A Chi-square test for independence (with Yates Continuity Correction) 
indicated that there was a significant association between child gender and health care 
provider recommendation, χ² (1, n= 273) = 6.43, p=.011, phi=-.161. There was no 
significant association between child gender and vaccine completion or initiation.  
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Parent Gender. There was a significant difference in uncertainty for 
vaccination scores between male parents (M=52.51, SD=10.10) and female parents 
(M=48.82, SD=9.75); t (289) = -2.76, p= .003, two-tailed. There were no significant 
differences in scores for parent gender on TTM variables or perceived harm, barriers, 
or effectiveness for vaccination scores. A Chi-square test for independence (with 
Yates Continuity Correction) indicated that there was a significant association 
between parent gender and vaccine initiation, χ² (1, n= 292) = 4.37, p=.037, phi=.130 
and parent gender and vaccine completion, χ² (1, n= 292) = 4.092, p=.043, phi=.126. 
There was no significant association between parent gender and health care provider 
recommendation.  
 Parent Education. ANOVA revealed mean scores on the self-efficacy 
measure differed significantly by parent’s level of education, F(2, 289)=4.202, p=.016. 
No significant group differences were found between parent education and pros, cons, 
or CHIAS variables. There was no significant association between parent education 
and vaccine completion, initiation, or health care provider recommendation.  
Geographical Region. The ANOVA showed mean scores on the cons measure 
differed significantly by region, F(3, 288)=2.886, p=.036. No significant group 
differences were found between region and pros, self-efficacy, or CHIAS variables. 
There was no association between region and vaccine completion, initiation, or health 
care provider recommendation.  
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Household income. The ANOVA showed mean scores on the perceived 
effectiveness measure differed significantly by household income, F(4, 279)=3.12, 
p=.016. Mean scores on the uncertainty measure also differed significantly by 
household income, F(4, 279)=3.52, p=.008. No significant differences were found 
between household income on TTM variables or perceived harm or barriers.  
Hypothesis Testing 
 Hypothesis 1: When parents/caregivers have received a health care 
provider’s recommendation, their child will be more likely to have initiated the 
vaccine series. A logistic regression analysis was performed to assess the relationship 
between health care provider recommendation and child vaccine initiation (received at 
least one shot in the series). The model contained health care provider 
recommendation as the independent variable (0=no health care provider 
recommendation; 1=health care provider recommendation). The ‘odds ratio’ for 
recommendation was 11.73 with a 95% confidence interval of [6.63-20.75], p < .000. 
This suggests that those who were recommended be their health care provider are 
almost 12 times more likely to initiate the vaccine compared to those who did not 
receive the recommendation (see Table 5).  
Hypothesis 2: When parents perceive the vaccine as effective (as measured 
by the CHIAS effectiveness subscale), their child will be more likely to have 
initiated the vaccine series. A logistic regression analysis was performed to assess 
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the relationship between parent’s perception of vaccine effectiveness and child 
vaccine initiation.  The model contained vaccine effectiveness as the continuous 
independent variable. The ‘odds ratio’ for perceived effectiveness was 1.08 with a 
95% confidence interval of [1.05-1.11], p<.000. This suggests that for each one unit 
increase in perceived vaccine effectiveness, the children were 8% more likely to have 
initiated the vaccine series (see Table 5). The range for this scale was 2-8, so 
participants with a score of 3 are 8% more likely to have initiated the vaccine 
compared to participants with a score of 2.  
Hypothesis 3: When parents perceive the vaccine to be potentially harmful 
(as measured by the CHIAS perceived harm subscale), their child will be less 
likely to have completed the vaccine series. A logistic regression analysis was 
performed to assess the relationship between parent’s perception of potential harm 
caused by the vaccine and child vaccine initiation. The model contained potential 
harm as the continuous independent variable. The ‘odds ratio’ for perceived harm was 
.96 with a 95% confidence interval of [.936-.982], p<.001. This suggests that for each 
one unit increase in perceived harm, the children were 4% less likely to have initiated 
the vaccine series (see Table 5).  The range for this scale was 6-24, so participants 
with a score of 7 are 4% less likely to have initiated the vaccine compared to 
participants with a score of 6.  
 Hypothesis 4: When parents perceive barriers to vaccination (as 
measured by the CHIAS perceived barriers subscale), their child will be less 
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likely to have initiated the vaccine series. A logistic regression analysis was 
performed to assess the relationship between parent’s perception of barriers to 
vaccination and child vaccine initiation. The model contained perceived vaccine 
barriers as the continuous independent variable. The ‘odds ratio’ for perceived barriers 
was 1.04 with a 95% confidence interval of [1.02-1.06], p<.003. This suggests that for 
each one unit increase in perceived vaccine barriers, the children were 4% more likely 
to have initiated the vaccine series (see Table 5). The range for this scale was 5-20, so 
participants with a score of 6 are 4% more likely to have initiated the vaccine 
compared to participants with a score of 5.  
Hypothesis 5: When parents feel uncertain about the vaccine (as measured 
by the CHIAS uncertainty subscale), their child will be less likely to have 
initiated the vaccine. A logistic regression analysis was performed to assess the 
relationship between parent’s feelings of uncertainty about the vaccine and child 
vaccine initiation. The model contained uncertainty as the continuous independent 
variable. The ‘odds ratio’ for uncertainty was .97 with a 95% confidence interval of 
[.95-1.00], p=.076, and was not statistically significant. This suggests that the model 
was not able to distinguish between respondents who reported and did not report 
vaccine initiation (see Table 5).  
Hypothesis 6: Given the findings related to racial/ethnic differences in 
vaccine adoption rates, the percent initiating the vaccine series will differ by 
racial/ethnic group. Racial and ethnic minorities will be less likely to have 
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initiated the vaccine series. Logistic regression analysis was performed to assess the 
relationship between race and ethnicity and child vaccine initiation. The model 
contained race (0=white; 1=non-white) as the independent variable. The ‘odds ratio’ 
for race was 1.24 with a 95% confidence interval of [.75-2.05], p=.40, and was not 
statistically significant.  The second model contained ethnicity (0=non-Latino; 
1=Latino) as the independent variable. The ‘odds ratio’ for ethnicity was 1.16 with a 
95% confidence interval of [.57-2.37], p=.684, and was not statistically significant. 
These results suggest that the model was not able to distinguish between respondents 
who reported and did not report vaccine initiation (See Table 5).  
 Hypothesis 7: Given the findings related to gender differences in vaccine 
adoption rates, male children will be less likely to have initiated the vaccine 
series. A logistic regression analysis was performed to assess the relationship between 
child’s gender and child vaccine initiation.  The model contained child gender 
(0=female; 1=male) as the independent variable. The ‘odds ratio’ for gender was 1.37 
with a 95% confidence interval of [.87-2.18], p=.178, and was not statistically 
significant. This suggests that the model was not able to distinguish between 
respondents who reported and did not report vaccine initiation (See Table 5).  
Hypothesis 8: Given the findings related to gender differences in vaccine 
uptake rates, among parents who haven’t initiated the vaccine, those with sons 
will be less willing to initiate vaccination as they may perceive that their sons are 
less likely to benefit from the vaccine when compared to parents of daughters. A 
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logistic regression was performed to assess the relationship between child gender and 
stage of change. The model contained child gender (0=male; 1=female) as the 
independent variable and Stage of Change (0=Precontemplation and Contemplation 
collapsed; 1=Preparation) as the dependent variable. The ‘odds ratio’ for gender was 
1.2 with a 95% confidence interval of [.60-2.4], p=.577, and was not statistically 
significant. This suggests that the model was not able to distinguish between 
respondents who were in Precontemplation/Contemplation and Preparation (See Table 
5).  
Hypothesis 9: Parents who talked to their child about HPV vaccination 
will be more likely than those who had not to have also talked with them about 
safe sex, as measured by the UNC Mother-Daughter Survey. A logistic regression 
analysis was performed to assess the relationship between parents talking to their child 
about the HPV vaccine and parents also talking to their child about safe sex topics. 
The model contained HPV discussion (0=did not talk to child about HPV; 1=did talk 
to child about HPV) as the independent variable. The ‘odds ratio’ for discussing HPV 
vaccination was 2.90 with a confidence interval of [1.90-4.42], p<.000. This suggests 
that those who discussed HPV vaccination with their child were almost three times 
more likely to have also discussed safe sex (see Table 5).  
Hypothesis 10: In accordance with the TTM’s decisional balance 
construct, the children of parents who have more pros and fewer cons for 
receiving the HPV vaccination will be more likely to have initiated the vaccine 
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series, as measured by the Decision Balance for HPV scale. A logistic regression 
analysis was performed to assess the relationship between pros and cons for receiving 
the HPV vaccine and child vaccine initiation. Two logistic regressions were run. The 
first used pros and the second used cons as the continuous independent variable. The 
‘odds ratio’ for pros was 1.06 with a 95% confidence interval of [1.05-1.10], p<.000. 
This suggests that for each one unit increase in pros, the child was 6% more likely to 
have initiated the vaccine. The range for this scale was 4-20, so participants with a 
score of 5 are 6% more likely to have initiated the vaccine compared to participants 
with a score of 4.  
The ‘odds ratio’ for cons was 1.05 with a 95% confidence interval of [1.02-
1.07], p<.000. This suggests that for each one unit increase in cons, the child was 5% 
more likely to have initiated the vaccine (See Table 5). The range for this scale was 4-
20, so participants with a score of 5 are 5% more likely to have initiated the vaccine 
compared to participants with a score of 4.  
 
Hypothesis 11: The children of those parents who have more vaccine self-
efficacy (i.e., higher confidence) will be more likely to have initiated the vaccine 
series, as measured by the Self-efficacy for HPV scale. A logistic regression 
analysis was performed to assess the relationship between self-efficacy and child 
vaccine initiation.  The model contained self-efficacy as the continuous independent 
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variable. The ‘odds ratio’ was 1.07 with a 95% confidence interval of [1.04-1.10], 
p<.000. This suggests that for each one unit increase in self efficacy, the child was 7% 
more likely to have initiated the vaccine (See Table 5). The range for this scale was 6-
30, so participants with a score of 7 are 7% more likely to have initiated the vaccine 
compared to participants with a score of 6.  
Hypothesis 12: When all significant variables are looked at together, TTM 
variables (decisional balance, self-efficacy) will be the strongest predictors of 
HPV vaccine initiation. A multivariate logistic regression analysis was performed to 
assess of the relationship between the variables that were found to be significant in the 
univariate logistic regressions and child vaccine initiation.  The model contained seven 
independent variables (healthcare provider recommendation, perceived vaccine 
effectiveness, perceived harm, barriers to vaccination, pros, cons, and self-efficacy). 
As shown in Table 8, three of the independent variables made a unique statistically 
significant contribution to the model (healthcare provider recommendation, barriers to 
vaccination, and perceived harm to vaccination). The strongest predictor of reporting 
vaccine initiation was healthcare provider recommendation, recording an odds ratio of 
18.84 and a 95% confidence interval of [8.96-39.63], p<.000. This indicates that 
respondents who received a healthcare provider recommendation were over 18 times 
more likely to have initiated the vaccine series, controlling for all other factors in the 
model. See Table 6. 
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Hypothesis 13: TTM measures of decisional balance and self-efficacy will 
be validated in a population of male and female parents/caregivers. The eight 
items of the Decisional Balance for HPV vaccination scale were subjected to 
confirmatory factor analysis (CFA) using structural equation modeling in EQS 
software (see Figure 1). Four models were tested: (1) null model (suggesting no latent 
factors and used as a comparative model), (2) one factor, (3) two uncorrelated Pros 
and Cons factors, and (4) two correlated Pros and Cons factors. The two-factor 
correlated model demonstrated the best fit, χ² (19)=66.65, p<.05, CFI= .964, 
GFI=.948,RMSEA=.093, and AASR= .045. The correlation between the Pros and 
Cons scales was .051.  
 The six items of the Self-efficacy for HPV vaccination scale were subjected to 
CFA (see Figure 2). Two models were tested: the null model and a one-factor model. 
The one-factor model demonstrated the best fit, χ² (9)=29.26, p<.05, CFI= ..977, 
GFI=.968, RMSEA=.088, and AASR= .020.  
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Discussion 
 The current study examined sociocultural predictors of parents’ and caregivers’ 
decisions to vaccinate their children against HPV. The study extends previous research 
by examining a diverse national sample of parents and caregivers. The data was 
census balanced for race/ethnicity and region of origin and male and female 
respondents were surveyed about their beliefs about the HPV vaccine as it relates to 
both male and female children. It is also one of few studies to compare male and 
female parents’ attitudes about HPV vaccination. Most previous studies examining 
parents’ attitudes and beliefs surveyed mothers or female caregivers only. Some 
attempted to survey both male and female caregivers (Brewer, et al, 2011; Guerry et 
al., 2011; Gilkey et al., 2012) but found that most respondents were female (between 
88-91%). The current study found that 31.8% of the respondents were male, allowing 
for a deeper understanding of male caregivers’ attitudes and the role they play in 
deciding to vaccinate their children. Additionally, this is one of few studies to compare 
male and female children and contributes to an emerging body of literature reporting 
rates of HPV vaccine initiation among young males. Almost 46% of the children 
described in the study were male. Finally, this is the first study to examine TTM 
variables related to HPV vaccination among parents and caregivers of children and 
adolescents that are eligible for the HPV vaccine. 
 The modal participant identified as a white, heterosexual mother and was 
married, had a 4-year degree or higher, had an estimated household income of 75,000 
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or higher, was born in the United States, currently living in the northeast, and had two 
children. The modal child described by respondents was female, white, and had not 
completed the HPV vaccine series. Surprisingly, more male children initiated the 
vaccine than female children (54% vs. 46%) though Centers for Disease Control and 
Prevention reported that nationally 53% of female adolescents had received at least 
one shot and only 21% of male adolescents had received on shot (Centers for Disease 
Control and Prevention, 2013).  
Sociocultural Predictors 
 Health care provider recommendation. Consistent with past research 
indicating that health care provider recommendation is a strong predictor of HPV 
vaccination (Gilkey, Moss, McRee, & Brewer, 2012; Reiter, Brewer, & Smith, 2010; 
Reiter, Brewer, McRee et al., 2010; Ylitalo, Lee, Mehta, 2012), health care provider 
recommendation was found to be the strongest predictor of vaccine initiation and 
respondents who reported that their child received a health care provider 
recommendation were 18 times more likely to have initiated. This finding is especially 
important as researchers have found that providers are less likely to recommend the 
vaccine to boys and racial/ethnic minorities which may contribute to the lower 
vaccination rates found among these groups (Gilkey, Moss, MeRee, & Brewer, 2012; 
Ylitalo, Lee, Mehta, 2012). These findings highlight the need for more effective 
methods to promote vaccination recommendation among health care providers to 
 
 
32 
 
ensure that all demographic groups are receiving the same recommendations and 
information.  
 Race/ethnicity and Socioeconomic Status. Contrary to previous findings 
(Mays, Stru, & Zimet, 2004; Jain et al., 2009), race and ethnicity did not predict 
vaccine initiation or completion and there were no significant differences found across 
race/ethnicity on TTM or CHIAS variables, vaccine initiation or completion, or health 
care provider recommendation. In fact, more racial and ethnic minorities had initiated 
the vaccine than white respondents (53.4% vs. 48%) and more than half of non-white 
respondents’ children had initiated the vaccine.  
Perhaps some of the disparities found in previous studies can be better 
explained by socioeconomic factors. The current study found that parents with 4-years 
of college education or higher reported significantly higher self-efficacy for 
vaccinating their child against HPV as compared to parents with less education. In 
addition, parents living in households with an annual income of $75,000 or more 
reported significantly higher scores for perceived vaccine effectiveness.  
Regional differences in vaccine uptake have previously been found. HPV 
vaccine coverage was highest in the Northeast and lowest in the South (Centers for 
Disease Control and Prevention, 2013). Related to these previous findings, current 
respondents living in the West reported significantly more cons for vaccinating their 
child followed by the South, Midwest, and Northeast. This is particularly troublesome 
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given the increased cervical cancer disparities among women living in low-income 
regions with limited healthcare access like the Appalachian South (Katz et al., 2009). 
Three primary barriers have been identified for Appalachian women, misinformation 
about HPV and the HPV vaccine, tangible barriers, and ambiguous information 
sources (Mills, Head, Vanderpool, 2013). In addition, many communities are 
experiencing growing numbers of parents who are delaying and/or refusing available 
recommended vaccinations for their children (Larson, Jarrett, Eckersberger, Smith, & 
Paterson, 2014; Dube, Vivion, & MacDonald, 2015; Dube, Gagnon, Nickels, Jeram, 
Schuster, 2014) which may explain why respondents in the West reported more cons 
for vaccination.  
Taken together, these findings indicate that parents from higher socioeconomic 
households feel more confident that they will vaccinate their child for HPV and 
perceive the vaccine to be more effective.  Conversely, some parents may be a part of 
the “anti-vaccine movement” and see many more cons to vaccination than others and 
the reasons for this are often complex and context-specific (Larson, Jarrett, 
Eckersberger, Smith, & Paterson, 2014).  Health care providers should use clear and 
purposeful communication about the development of HPV related cancers and the 
purpose and safety of the vaccine. Additionally, marketing and social marketing 
practices may be used to foster vaccine acceptance (Nowak, Gellin, MacDonald, & 
Butler, 2015). 
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 Gender. Based on previous findings (Linddon, Hood, Wynn, and Markowitz, 
2010; Centers for Disease Control, 2013), it was hypothesized that male children 
would be less likely to have initiated the vaccine, however, gender did not predict 
vaccine initiation or completion. While gender was not predictive of vaccine uptake, 
exploratory analyses found differences that were similar to previous findings 
(Berenson & Rahman, 2012; Gilkey, Moss, McRee, & Brewer, 2012). There were 
significant differences between parent’s attitudes and beliefs about vaccinating male 
vs. female children. Parents and caregivers indicated that they had more cons, 
perceived more harm, and perceived more barriers for vaccinating male children as 
compared to female children. Female children also appeared to receive a larger percent 
of health care provider recommendations to vaccinate as compared to male children 
(56% vs. 43.6%). Despite these differences, 54% of male children in the study had 
initiated the vaccine and 38% had completed the vaccine series. This may partially be 
explained by the slight increase in HPV vaccine uptake among males in recent years 
(Pierre-Victor, Mukherjee, Bahelah, & Madhivanan, 2014) and the implementation of 
the Patient Protection and Affordable Care Act of 2010 (Centers for Disease 
Prevention and Control, 2013).  
Additionally, there were significant differences found between parents’ gender 
and vaccine initiation/completion. While male parents reported more uncertainty about 
vaccinating their children, they reported that more of their children had initiated the 
vaccine and completed the vaccine as compared to female respondents (59% vs. 45%; 
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44% vs. 31%). It is difficult to hypothesize about this finding given the dearth of 
research in this area. Most studies examining parents’ decisions to vaccinate their 
children include very little information about male parents’ perspectives (May, Sturm, 
& Zimet, 2004; Downs, de Bruin, & Fishhoff, 2008; Trim, Nagji, Elit, & Roy, 2011). 
 Parent-child Communication. Parents who talked to their children about 
HPV vaccination were almost three times more likely to have also talked to them 
about safe sex practices. Many parents rely on situations that arise spontaneously to 
prompt conversations with their children about safe sex (Rosenthal, Feldman, & 
Edwards, 1998; O’Sullivan, Meyer-Bahlburg, & Watkins, 2001). These findings 
suggest that discussions about the vaccine may provide parents with an opportunity to 
talk with their children about STIs and the importance of safe sex. Perhaps health care 
providers could use HPV vaccine recommendation as a cue to talk to parents about 
using the vaccine to prompt a conversation about safe sex as parent-child 
communication about sex is associated with decreased sexual risk taking during 
adolescence and an older age at sexual debut (DeClemente et al., 2001; Miller et al., 
1998).  
CHIAS Predictors  
 As hypothesized, perceived effectiveness and perceived harm predicted 
vaccine initiation. The results indicated that as the respondents’ perceived 
effectiveness increased, the likelihood that their child had initiated the vaccine 
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increased. As the respondents’ perceived harm increased, the likelihood that their child 
had initiated the vaccine decreased. Interestingly, as respondents’ perceived barriers 
increased, the likelihood that their child had initiated the vaccine increased. 
Respondents’ mean score on effectiveness was higher than their mean score on 
barriers. Perhaps these parents’ high level of perceived vaccine effectiveness helped 
them to overcome the perceived barriers. Additionally, most questions on the barriers 
subscale addressed vaccine affordability and availability. Implementation of the 
Patient Protection and Affordable Care Act of 2010 now requires private health care 
plans to offer, at no cost to beneficiaries, vaccines recommended by ACIP (Centers for 
Disease Prevention and Control, 2013), these changes could have helped respondents 
to overcome some barriers and initiate vaccination.  
Previously, health care providers reported that parental beliefs, perceptions, 
and misconceptions about the vaccine acted as barriers to HPV vaccination in a clinic 
serving a predominantly Hispanic population (Javanbakht et al., 2012). Taken 
together, these findings highlight the importance of providing parents with accurate 
information about vaccine harm and effectiveness. Vaccine misconceptions could be 
addressed with education about the need for child and adolescent vaccines, the safety 
of the vaccine, and availability of the vaccine.  
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TTM Predictors   
 As hypothesized, the TTM variables (decisional balance and self-efficacy) 
were predictors of vaccine initiation. The results indicated that as the number of pros 
increased, the likelihood of vaccine initiation increased. As respondents reported 
greater self-efficacy for vaccination, the likelihood of vaccine initiation increased. 
Surprisingly, as the number of cons increased, the likelihood of vaccine initiation also 
increased. Respondents indicated a large number of both pros and cons, but overall 
they reported more pros. Literature on other health behaviors supports the importance 
of pros on health behavior decision making. Part of the decision to move towards 
action/maintenance (initiation of the vaccine and ultimately completion of all three 
shots) is based on the relative weight given to the pros and cons of making a 
behavioral change. Pros may be thought of as facilitators of change (Prochaska, et al., 
1994) which would explain why respondents weighing more pros for vaccination 
would be more likely to have made a behavioral change (initiating the vaccine). 
Alternatively, it is possible that the cross-sectional design of the study limited our 
assessment of the relationship between pros and vaccine completion. Many of the 
respondents reported that their child had already started the vaccine series. Vaccine 
initiation could be impacting the parent’s rating of their pros and cons for vaccination.  
 As hypothesized, the TTM measures for decisional balance and self-efficacy 
for HPV vaccination were validated in a sample of parents and caregivers. This adds 
three new TTM-based measures to the literature. These measures can be used to 
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understand behavior change among parents of children that are eligible to receive the 
HPV vaccine and will promote vaccination research.  
Limitations 
 There are several limitations to this study that should be considered. Parents 
and caregivers reported their child’s vaccination status, leaving room for errors in 
reporting. It is possible that their child’s other parent or guardian is responsible for 
taking them to see their health care provider and that they might have more accurate 
information about their child’s vaccination status. The results are based on a 
convenience sample as 71.2% of the respondents used SSI to complete the survey and 
28.8% were recruited informally (via emailing the survey to colleagues). Participants 
recruited though SSI earn points for completing surveys and exchange them for small 
prizes. Although the sample was reflective of the racial/ethnic and regional breakdown 
of the United States, participants that are willing and able to commit time to 
completing online surveys may have unique characteristics. For example, the sample 
was not diverse in terms of socioeconomic status as almost half of the respondents 
reported an annual household income of $75,000 of greater and over half had earned a 
4-year degree or higher. Given this homogeneity, the relationship between 
socioeconomic status and vaccine initiation was unable to be fully explored. Future 
research will be required to determine generalizability. 
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Future Directions 
 Notwithstanding these warnings, this study provides a number of meaningful 
conclusions that will help further investigation of HPV vaccine behaviors among 
children and adolescents. Low adherence to vaccine recommendation is an issue of 
major public health concern. To our knowledge, this is the first study to validate TTM 
measures for HPV vaccination with a sample of parents and caregivers. It is also the 
first study to examine sociocultural characteristics and TTM variables as they relate to 
both male and female parents’ decisions to vaccinate their children against HPV. 
Given that pros, self-efficacy, and perceived effectiveness were found to be predictive 
of vaccine initiation, these variable appear to make a difference in whether a parent 
chooses to vaccinate their child. However, the respondents’ pros, self-efficacy, and 
perceived effectiveness may have increased following vaccine initiation. A 
longitudinal design would be helpful in determining whether these variables predict 
vaccine initiation or if vaccine initiation predict an increase in those variables.  
  These findings may inform future TTM-tailored interventions aimed at 
increasing HPV vaccine initiation among children and adolescents. Further, 
population-based approaches to increasing HPV vaccination may be possible and are 
likely to have the most impact on reducing rates of HPV related cancers. Previous 
research has illustrated the utility of tailored approaches to interventions that can be 
provided on a population basis (Krebs, Prochaska, & Rossi, 2010). Future studies 
should also assist in developing tailored approaches to interventions for both health 
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care providers and parents and caregivers. Future work should examine ways to ensure 
that health care providers are providing equivalent information about vaccination to all 
patients regardless of race/ethnicity, gender, and socioeconomic status. Additionally, 
researchers should examine ways to increase parents’ pros, self-efficacy, and 
perceived effectiveness for HPV vaccination for sons as well as daughters.  
Conclusions 
  The current study examined sociocultural predictors of parents’ and caregivers’ 
decisions to vaccinate their children against HPV. Health care provider 
recommendation, perceived vaccine effectiveness, pros for vaccination, and self-
efficacy increased the likelihood that children had initiated the HPV vaccine. While no 
significant differences were found for race/ethnicity and gender on vaccine initiation, 
some disparities were noted. There were regional differences in perceived cons for 
vaccination, socioeconomic differences in self-efficacy and perceived effectiveness, 
and gender differences in health care provider recommendation and parent perception 
of cons, vaccine harm, and barriers. These findings may inform future, tailored 
interventions aimed at increasing HPV vaccine initiation among children and 
adolescents. 
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Table 1. Demographics 
 
Parent Demographics 
 % N 
Parent Race/Ethnicity     
White 69.9 204 
Latino/Latina 11.6 34 
Black/African American 11 32 
Asian  4.8 14 
American Indian 1.4 4 
Native Hawaiian or Pacific Islander 0.3 1 
Other  1 3 
Parent Status    
Mother 63 184 
Father 28.4 83 
Female Guardian or Caregiver 5.1 15 
Male Guardian or Caregiver 3.4 10 
Parent Sexual Orientation   
Heterosexual 93.5 273 
Lesbian or Gay 1.4 4 
Bisexual 3.8 11 
Pansexual 0.3 1 
Prefer not to Answer 1 3 
Marital Status   
Married 77.4 226 
In a Relationship and Living with Partner 6.2 18 
In a Relationship and not Living with Partner  0.7 2 
Single, Never Married 7.9 23 
Divorced 4.8 14 
Separated 1 3 
Widowed  1.4 4 
Domestic Partnership 0.7 2 
Parent Education    
Four Years of Higher 52.7 154 
Some College 35.6 104 
HS Diploma/GED or Below 11.6 34 
Household Income   
Under 25,000 9.1 26 
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25,000-50,000 18.9 54 
50,000-75,000 22.1 63 
75,000 or More 45.9 134 
Choose not to Answer 2.7 8 
Parent Demographics Continued 
  % N 
Geographic Region     
South  30.1 88 
Northeast 35.1 103 
Midwest 21.6 63 
West 13 38 
Number of Children     
1 61 20.9 
2 111 38 
3 69 23.6 
4 32 11 
5 14 4.8 
More than 5 5 1.7 
Child Demographics 
Child Race/Ethnicity     
White 194 66.4 
Latino/Latina 31 10.6 
Black/African American 34 11.6 
Asian  12 4.1 
American Indian 3 1 
Native Hawaiian or Pacific Islander 2 0.7 
Other  16 5.5 
Child Gender     
Female 158 54.3 
Male 133 45.7 
Child Vaccination Status 
Completed Vaccine Series     
Yes 103 35.3 
No 189 64.7 
Initiated Vaccine Series (One or More Shots)     
Yes 145 49.7 
No 147 50.3 
Healthcare Provider Recommended Vaccine     
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Yes 147 50.3 
No 126 43.2 
Don’t Know 19 6.5 
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Table 2 Descriptive Statistics and Cronbach’s Alpha for Measures  
Measure  
# of 
items 
M SD 
Possible 
range 
Alpha 
TTM Variables        
Pros  4 4.03 0.98   4-20   0.86 
Cons 4 2.16 1.25   4-20   0.88 
Self-efficacy 6 3.23 1.08   6-30    0.89 
CHIAS Variables       
Perceived Harm 6 2.47 0.76   6-24 0.84 
Barriers 5 1.79 0.88   5-20 0.92 
Effectiveness 2 2.62 0.83   2-8 0.83 
Uncertainty 3 2.57 0.7   3-12 0.45 
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Table 3 Race and Gender by TTM & CHIAS variables 
Parent Race White Non-White t p 
 M SD M SD     
Pros 46.64 10.17 50.82 9.61 -0.93 0.36 
Cons 49.61 10.3 50.91 9.26 -1.02 0.31 
Self-efficacy 50.51 10.33 48.82 9.11 1.33 0.18 
Perceived Harm 50.22 10.32 49.48 9.24 0.58 0.56 
Barriers 49.77 10.48 50.52 8.82 0.67 0.5 
Effectiveness 50.26 10.34 49.4 9.21 0.67 0.5 
Uncertainty 50.6 10.12 48.66 9.65 1.5 0.13 
Child Gender Female Male t p 
 M SD M SD     
Pros 49.2 10.44 50.87 9.4 -1.42 0.16 
Cons 47.85 8.83 52.48 10.73 -4.04 .000** 
Self-efficacy 49.11 10.06 51.07 9.89 -1.66 0.09 
Perceived Harm 48.85 9.58 51.24 10.31 -2.04 .04* 
Barriers 47.89 8.69 52.51 10.89 -4.01 .000** 
Effectiveness 48.66 10.48 51.73 9.04 -2.64 .009* 
Uncertainty 49.84 10.29 50.14 9.71 -0.25 0.8 
Parent Gender Female Male t p 
  M SD M SD    
Pros 50.35 10.29 49.26 9.37 0.86 0.38 
Cons 47.3 8.73 55.78 10.13 -7.35 .000** 
Self-efficacy 49.51 10.7 51.05 8.26 -1.23 0.22 
Perceived harm 48.32 9.98 53.59 9.08 -4.32 .000** 
Barriers 46.78 8.17 56.85 10.12 -9.06 .000** 
Effectiveness 49.3 10.17 51.49 9.51 -1.75 0.08 
Uncertainty 48.82 9.76 52.51 10.1 -2.98 .003* 
 
 
 
  
 
 
Table 4 Parent Education, Geographic Region, and Household income by TTM & CHIAS variables 
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Table 5. Univariate Logistic Regression Results 
  95% C.I.  
  Odds Ratio Lower  Upper Sig. 
HPV Variables      
Health care recommendation  11.73 6.63 20.75 .000** 
Talked about HPV 
vaccination  2.90 1.90 4.42 .000** 
Demographics     
Race 1.24 0.75 2.05 0.40 
Ethnicity 1.16 0.57 2.38 0.68 
Child Gender 1.37 0.85 2.18 0.18 
CHIAS measures     
Effectiveness 1.08 1.05 1.11 .000** 
Perceived harm 0.96 0.94 0.98 .001** 
Barriers 1.04 1.02 1.06 .003* 
Uncertainty  0.97 0.95 1.00 0.08 
TTM measures     
Pros 1.08 1.05 1.10 .000** 
Cons 1.05 1.02 1.07 .000** 
Self-efficacy 1.07 1.04 1.10 .000** 
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Table 6. Multivariate Logistic Regression Results  
  95% C.I.  
  Odds Ratio Lower  Upper Sig. 
HPV Variables      
Health care recommendation  18.84 8.96 39.63 .000** 
CHIAS measures     
Effectiveness 1.04 0.99 1.09 0.06 
Perceived harm 0.91 0.86 0.96 .000** 
Barriers 1.08 1.03 1.15 .003* 
TTM measures     
Pros 1.04 0.99 1.08 0.08 
Cons 1.04 0.98 1.09 0.13 
Self-efficacy 1.03 0.98 1.06 0.22 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
Figure 1 CFA Decisional Balance model  
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Figure 2 CFA Self-efficacy model  
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